Manufacturer copay assistance · Orbactiv (J2407) · Melinta Therapeutics
$50/dose · Maximum benefit Up to $600 per treatment — patient must have minimum $50 copay obligation · Covers ORBACTIV drug copay/coinsurance up to $600 per treatment
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Orbactiv — check the full fund board.
Yes — ORBACTIV Copay Savings Program from Melinta Therapeutics. Patient pays $50 toward copay/coinsurance; program covers up to $600 of remaining obligation. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Patient pays $50 toward copay/coinsurance; program covers up to $600 of remaining obligation Maximum benefit: Up to $600 per treatment — patient must have minimum $50 copay obligation. Covers ORBACTIV drug copay/coinsurance up to $600 per treatment
Accepted insurance: commercial. Not eligible: medicare, medicaid, government, tricare. Income limit: Must be US resident, 18+ years old, with minimum $50 copay obligation.